Impact of video-assisted thoracoscopic major lung resection on immune function

Asian Cardiovascular and Thoracic Annals

Volumn 17, Issue 4, 2009, Pages 426-432

  Ng, Calvin S H ^a   Wan, Innes Y P ^a   Yim, Anthony P C ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Immune system; Lung neoplasms; Thoracic surgery; Video assisted

Indexed keywords

ANGIOGENIC FACTOR; SOMATOMEDIN BINDING PROTEIN 3; VASCULOTROPIN; AUTACOID; CYTOKINE;

CANCER STAGING; CANCER SURGERY; CELLULAR IMMUNITY; CLINICAL TRIAL; COMPARATIVE STUDY; ENDOSCOPIC SURGERY; HUMAN; IMMUNE RESPONSE; LENGTH OF STAY; LUNG NON SMALL CELL CANCER; LUNG RESECTION; NATURAL KILLER CELL; POSTOPERATIVE INFLAMMATION; POSTOPERATIVE PAIN; REVIEW; SURVIVAL TIME; T LYMPHOCYTE ACTIVATION; THORACOSCOPY; THORACOTOMY; IMMUNOLOGY; INFLAMMATION; LUNG TUMOR; METABOLISM; METHODOLOGY; MORTALITY; T LYMPHOCYTE; THORAX SURGERY; TIME; TREATMENT OUTCOME;

CARCINOMA, NON-SMALL-CELL LUNG; CYTOKINES; HUMANS; IMMUNITY, CELLULAR; INFLAMMATION; INFLAMMATION MEDIATORS; LUNG NEOPLASMS; PNEUMONECTOMY; T-LYMPHOCYTES; THORACIC SURGERY, VIDEO-ASSISTED; THORACOTOMY; TIME FACTORS; TREATMENT OUTCOME;

EID: 70350705588     PISSN: 02184923     EISSN: None     Source Type: Journal    
DOI: 10.1177/0218492309338100     Document Type: Review

References (46)

1. Shiraishi T, Shirakusa T, Hiratsuka M, Yamamoto S, Iwasaki A. Video-assisted thoracoscopic surgery lobectomy for c-T1N0M0 primary lung cancer: its impact on locoregional control. Ann Thorac Surg 2006;82:1021-1026 (Pubitemid 44246711)
2. Yim AP. VATS major pulmonary resection revisited-controversies, techniques, and results. Ann Thorac Surg 2002; 74:615-623
3. Nicastri DG, Wisnivesky JP, Litle VR, Yun J, Chin C, Dembitzer FR, et al. Thoracoscopic lobectomy: report on safety, discharge independence, pain, and chemotherapy tolerance. J Thorac Cardiovasc Surg 2008;135:642-647 (Pubitemid 351329327)
4. Petersen RP, Pham D, Burfeind WR, Hanish SI, Toloza EM, Harpole Jr DH, et al. Thoracoscopic lobectomy facilitates the delivery of chemotherapy after resection for lung cancer. Ann Thorac Surg 2007;83:1245-1250 (Pubitemid 46440786)
5. Kaseda S, Aoki T, Hangai N, Shimizu K. Better pulmonary function and prognosis with video-assisted thoracic surgery than with thoracotomy. Ann Thorac Surg 2000;70:1644-1646
6. Sawada S, Komori E, Yamashita M, Nakata M, Nishimura R, Teramoto N, et al. Comparison in prognosis after VATS lobectomy and open lobectomy for stage I lung cancer. Retrospective analysis focused on a histological subgroup. Surg Endosc 2007;21:1607-1611
7. Yamashita JI, Kurusu Y, Fujino N, Saisyoji T, Ogawa M. Detection of circulating tumor cells in patients with non-small cell lung cancer undergoing lobectomy by video-assisted thoracic surgery: a potential hazard for intraoperative hematogenous tumor cell dissemination. J Thorac Cardiovasc Surg 2000; 119:899-905. (Pubitemid 30327409)
8. Shigemura N, Akashi A, Funaki S, Nakagiri T, Inoue M, Sawabata N, et al. Long-term outcomes after a variety of video-assisted thoracoscopic lobectomy approaches for clinical stage 1A lung cancer: a multi-institutional study. J Thorac Cardiovasc Surg 2006;132:507-512 (Pubitemid 44278879)
9. Ng CS, Whelan RL, Lacy AM, Yim AP. Is minimal access surgery for cancer associated with immunologic benefits? World J Surg 2005;29:975-981
10. Vittimberga Jr FJ, Foley DP, Meyers WC, Callery MP. Laparoscopic surgery and the systemic immune response. Ann Surg 1998;227:326-334 (Pubitemid 28131012)
11. Delgado S, Lacy AM, Filella X, Castells A, Garcia- Valdecasas JC, Pique JM, et al. Acute phase response in laparoscopic and open colectomy in colon cancer. Dis Colon Rectum 2001;44:638-664 (Pubitemid 32428710)
12. Leung KL, Lai PB, Ho RL, Meng WC, Yiu RY, Lee JF, et al. Systemic cytokine response after laparoscopic-assisted resection of rectosigmoid carcinoma: A prospective randomized trial. Ann Surg 2000;231:506-511
13. Craig SR, Leaver HA, Yap PL, Pugh GC, Walker WS. Acute phase responses following minimal access and conventional thoracic surgery. Eur J Cardiothorac Surg 2001;20:455-463
14. Yim AP, Wan S, Lee TW, Arifi AA. VATS lobectomy reduces cytokine responses compared with conventional surgery. Ann Thorac Surg 2000;70:243-247 (Pubitemid 30485756)
15. Nagahiro I, Andou A, Aoe M, Sano Y, Date H, Shimizu N. Pulmonary function, postoperative pain, and serum cytokine level after lobectomy: a comparison of VATS and conventional procedure. Ann Thorac Surg 2001;72:362-365 (Pubitemid 32727128)
16. Szczȩsny TJ, Slotwiński R, Szczygiel B, Stankiewicz A, Zaleska M, Kopacz M, et al. Systematic mediastinal lymphadenectomy does not increase postoperative immune response after major lung resections. Eur J Cardiothorac Surg 2007; 32:868-872 (Pubitemid 350052573)
17. Tsuruma T, Yagihashi A, Torigoe T, Sato N, Kikuchi K, Watanabe N, et al. Interleukin-10 reduces natural killer sensitivity and downregulates MHC class I expression on H-ras-transformed cells. Cell Immunol 1998;184:121-128 (Pubitemid 28265569)
18. Ng CS, Lee TW, Wan S, Wan IY, Sihoe AD, Arifi AA, et al. Thoracotomy is associated with significantly more profound suppression in lymphocytes and natural killer cells than video-assisted thoracic surgery following major lung resections for cancer. J Invest Surg 2005;18:81-88 (Pubitemid 40711408)
19. Chang KT, Tsai CM, Chiou YC, Chiu CH, Jeng KS, Huang CY. IL-6 induces neuroendocrine dedifferentiation and cell proliferation in non-small cell lung cancer cells. Am J Physiol Lung Cell Mol Physiol 2005;289:L446-53.
20. Wu Y, Yakar S, Zhao L, Hennighausen L, LeRoith D. Circulating insulin-like growth factor-I levels regulate colon cancer growth and metastasis. Cancer Res 2002;62:1030-1035 (Pubitemid 34160283)
21. Chang YS, Kong G, Sun S, Liu D, El-Naggar AK, Khuri FR, et al. Clinical significance of IGFBP-3 expression in stage I non-small cell lung cancer. Clin Cancer Res 2002;8:3796-3802 (Pubitemid 34517656)
22. Kirman I, Poltoratskaia N, Sylla P, Whelan RL. Insulin-like growth factor-binding protein 3 inhibits growth of experimental colocarcinoma. Surgery 2004;136:205-209. (Pubitemid 39037655)
23. Ng CS, Wan S, Hui CW, Wan IY, Lee TW, Underwood MJ, et al. Video-assisted thoracic surgery lobectomy for lung cancer is associated with less immunochemokine disturbances than thoracotomy. Eur J Cardiothorac Surg 2007;31:83-87 (Pubitemid 44880766)
24. Belizon A, Kirman I, Balik E, Karten M, Jain S, Whelan RL. Major surgical trauma induces proteolysis of insulin-like growth factor binding protein-3 in transgenic mice and is associated with a rapid increase in circulating levels of matrix metalloproteinase-9. Surg Endosc 2007;21:653-658 (Pubitemid 46439373)
25. Liotta LA, Tryggvason K, Garbisa S, Hart I, Foltz CM, Shafie S. Metastatic potential correlates with enzymatic degradation of basement membrane collagen. Nature 1980; 284:67-68 (Pubitemid 10098769)
26. Iizasa T, Fujisawa T, Suzuki M, Motohashi S, Yasufuku K, Yasukawa T, et al. Elevated levels of circulating plasma matrix metalloproteinase 9 in non-small cell lung cancer patients. Clin Cancer Res 1999;5:149-153 (Pubitemid 29045188)
27. Vittimberga Jr FJ, Foley DP, Meyers WC, Callery MP. Laparoscopic surgery and the systemic immune response. Ann Surg 1998;227:326-334
28. Brune IB, Wilke W, Hensler T, Holzmann B, Siewert JR. Downregulation of T helper type 1 immune response and altered proinflammatory and anti-inflammatory T cell cytokine balance following conventional but not laparoscopic surgery. Am J Surg 1999;177:55-60.
29. Decker D, Schondorf M, Bidlingmaier F, Hirner A, von Ruecker AA. Surgical stress induces a shift in the type-1/type-2 T-helper cell balance, suggesting down-regulation of cell mediated and up-regulation of antibody-mediated immunity commensurate to the trauma. Surgery 1996;119:316-325
30. Leaver HA, Craig SR, Yap PL, Walker WS. Lymphocyte responses following open and minimally invasive thoracic surgery. Eur J Clin Invest 2000;30:230-238
31. Inoue H, Ishihara T, Kobayashi K, Fukai S. Sequential evaluation of DNCB reactivity in patients with primary lung cancer. Correlation with prognosis. J Thorac Cardiovasc Surg 1978;76:479-482
32. Cannon GB, Dean JH, Herberman RB, Perlin E, Reid J, Miller C, et al. Association of depressed postoperative lymphoproliferative responses to alloantigens with poor prognosis in patients with stage I lung cancer. Int J Cancer 1980;25:9-17.
33. Uchida A, Kariya Y, Okamoto N, Sugie K, Fujimoto T, Yagita M. Prediction of postoperative clinical course by autologous tumorkilling activity in lung cancer patients. J Natl Cancer Inst 1990; 82:1697-1701
34. Fujisawa T, Yamaguchi Y. Autologous tumor killing activity as a prognostic factor in primary resected nonsmall cell carcinoma of the lung. Cancer 1997;79:474-481
35. Nakamura H, Saji H, Ogata A, Hosaka M, Hagiwara M, Kawasaki N, et al. Immunologic parameters as significant prognostic factors in lung cancer. Lung Cancer 2002;37:161-169
36. Nakamura H, Idiris A, Kato Y, Kato H. An increase in the percentage of HLA-DR-positive peripheral leukocytes predicts a poor prognosis in patients with squamous cell carcinoma of the lung. Oncol Rep 2004;11:673-676
37. Ito N, Suzuki Y, Taniguchi Y, Ishiguro K, Nakamura H, Ohgi S. Prognostic significance of T helper 1 and 2 and T cytotoxic 1 and 2 cells in patients with non-small cell lung cancer. Anticancer Res 2005;25:2027-2031
38. Sperduto P, Vaezy A, Bridgman A, Wilkie L. Spontaneous regression of squamous cell lung carcinoma with adrenal metastasis. Chest 1988;94:887-889
39. Darnell RB, DeAngelis LM. Regression of small-cell lung carcinoma in patients with paraneoplastic neuronal antibodies. Lancet 1993;341:21-22
40. Langrish CL, McKenzie BS, Wilson NJ, de Waal Malefyt R, Kastelein RA, Cua DJ. IL-12 and IL-23: master regulators of innate and adaptive immunity. Immunol Rev 2004;202: 96-105.
41. Trinchieri G. Interleukin-12: a cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T-helper cells type 1 and cytotoxic lymphocytes. Blood 1994;84:4008-4027
42. Benatar T, Cao MY, Lee Y, Li H, Feng N, Gu X, et al. Virulizin((R)) induces production of IL-17E to enhance antitumor activity by recruitment of eosinophils into tumors. Cancer Immunol Immunother 2008;57:1757-1769
43. Belizon A, Balik E, Horst P, Feingold D, Arnell T, Azarani T, et al. Persistent elevation of plasma vascular endothelial growth factor levels during the first month after minimally invasive colorectal resection. Surg Endosc 2008;22:287-297
44. Belizon A, Balik E, Feingold DL, Bessler M, Arnell TD, Forde KA, et al. Major abdominal surgery increases plasma levels of vascular endothelial growth factor: open more so than minimally invasive methods. Ann Surg 2006;244:792-798
45. Beilin B, Shavit Y, Trabekin E, Mordashev B, Mayburd E, Zeidel A, et al. The effects of postoperative pain management on immune response to surgery. Anesth Analg 2003;97:822-827
46. Shigemura N, Hsin MK, Yim AP. Segmental rib resection for difficult cases of video-assisted thoracic surgery. J Thorac Cardiovasc Surg 2006;132:701-702